Healthcare-Associated Infections: 2022 Annual Report

 

To: Facility administrators, infection preventionists.   From: Healthcare-Associated Infections and Antimicrobial Resistance Program   The Healthcare-Associated Infections (HAI) Annual Report for 2022 is now available. This report contains 2022 rates of HAIs that Colorado health care facilities report to the Colorado Department of Public Health and Environment via the National Healthcare Safety Network (NHSN). It includes infections associated with urinary catheters, central lines, dialysis, and surgeries. It also includes hospital-onset Clostridioides difficile infections. Rates of HAIs from 2021 are included for comparison.   In 2022, overall rates of the following conditions were lower (better) than the national baseline: Catheter-associated urinary tract infections in acute care hospitals overall and in adult and pediatric critical care units and wards. Central-line associated bloodstream infections in acute care hospitals overall and in adult and pediatric critical care units and wards. Clostridioides difficile infections in acute care hospitals, inpatient rehabilitation facilities, and long-term acute care hospitals. Surgical site infections following inpatient colon surgeries in acute care hospitals. Surgical site infections following outpatient knee replacement surgeries in acute care hospitals.   Overall rates of the following conditions were higher (worse) than the national baseline: Surgical site infections following inpatient breast surgeries in acute care hospitals. Surgical site infections following inpatient hip replacement surgeries in acute care hospitals. Surgical site infections following outpatient abdominal hysterectomies in acute care hospitals. Surgical site infections following knee replacement surgeries in ambulatory surgery centers.   Overall rates for other conditions were similar to the national baseline or suppressed due to small numbers of events.   Facility-specific rates of HAIs are presented in detail.   Read the full report here.